PATRICIA NOVOA-VOGT: Open Payments
NPI 1801375753 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,981 in 59 payments from 10 companies in 2025. Trend: 2023 $4,633 · 2024 $6,781 · 2025 $17,981
Speaker / faculty: $10,588Travel & lodging: $4,095Food & beverage: $1,876Consulting: $1,423
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $16,577 |
| Genmab U.S., Inc. | 1 | $735 |
| GlaxoSmithKline, LLC. | 13 | $189 |
| AstraZeneca Pharmaceuticals LP | 2 | $144 |
| PFIZER INC. | 1 | $118 |
| Merck Sharp & Dohme LLC | 1 | $102 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Janssen Biotech, Inc. | 1 | $26 |
| BeOne Medicines USA, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: ELAHERE, Epkinly, JEMPERLI, ELREXFIO, KEYTRUDA, DATROWAY, Enhertu, DARZALEX.
Industry payments across FL — which companies pay providers there.
